Multicenter Phase 2 Study about the Safety of No Antimicrobial Prophylaxis Use in Low-Risk Patients Undergoing Laparoscopic Distal Gastrectomy for Gastric Carcinoma (KSWEET-01 Study)

Oh Jeong, Mi Ran Jung, Seong Yeob Ryu, Young-Kyu Park, Min Chan Kim, Ki Han Kim, Seung Wan Ryu, In Gyu Kwon, Young Gil Son, Oh Jeong, Mi Ran Jung, Seong Yeob Ryu, Young-Kyu Park, Min Chan Kim, Ki Han Kim, Seung Wan Ryu, In Gyu Kwon, Young Gil Son

Abstract

Background: Recent studies have shown a lower risk of surgical site infections (SSI) after laparoscopic distal gastrectomy compared to open surgery. This is a phase 2 study aiming to determine the incidence of SSI after laparoscopic distal gastrectomy without using antimicrobial prophylaxis (AMP).

Methods: cT1N0 gastric cancers that were subject to laparoscopic distal gastrectomy were enrolled. Based on the unacceptable SSI incidence of ≥12.5% and the target SSI incidence of ≤5%, 105 patients were enrolled with an α of 0.05 and a power of 80% (ClinicalTrials.gov, NCT02200315).

Results: In intention-to-treat analysis, patients did not reach the target SSI rate (12.4%, 95% confidence interval = 6.8%-19.8%). Of patients, 44 patients had a protocol violation, such as extended lymph node dissection (LND) or inappropriate nonpharmacological SSI prevention measures. Per-protocol analysis excluding these patients (n = 61) showed a SSI rate of 4.9%, which was within the target SSI range. Multivariate analysis revealed that extracorporeal anastomosis and extended LND were independent risk factors for SSI.

Conclusions: This study failed to reach the target SSI rate without using AMP. However, per-protocol analysis suggests that no AMP might be feasible when limited LND and adequate SSI prevention measures were performed.

Figures

Figure 1
Figure 1
Consort flow diagram. ITT—intention-to-treat group; PP—per-protocol group; SSI—surgical site infection.

References

    1. Kitano S., Iso Y., Moriyama M., Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surgical Laparoscopy & Endoscopy. 1994;4:146–148.
    1. Jeong O., Park Y. K. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. Journal of Gastric Cancer. 2011;11:69–77. doi: 10.5230/jgc.2011.11.2.69.
    1. Vinuela E. F., Gonen M., Brennan M. F., Coit D. G., Strong V. E. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Annals of Surgery. 2012;255:446–456. doi: 10.1097/SLA.0b013e31824682f4.
    1. Kim W., Kim H. H., Han S. U., et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01) Annals of Surgery. 2016;263:28–35. doi: 10.1097/SLA.0000000000001346.
    1. Kim H. I., Han S. U., Yang H. K., et al. Multicenter prospective comparative study of robotic versus laparoscopic gastrectomy for gastric adenocarcinoma. Annals of Surgery. 2016;263:103–109. doi: 10.1097/SLA.0000000000001249.
    1. Lin J. X., Huang C. M., Zheng C. H., et al. Surgical outcomes of 2041 consecutive laparoscopic gastrectomy procedures for gastric cancer: a large-scale case control study. PloS One. 2015;10, article e0114948 doi: 10.1371/journal.pone.0114948.
    1. Bratzler D. W., Dellinger E. P., Olsen K. M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health-System Pharmacy. 2013;70:195–283. doi: 10.2146/ajhp120568.
    1. Mohri Y., Tonouchi H., Kobayashi M., Nakai K., Kusunoki M., Mie Surgical Infection Research G. Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. The British Journal of Surgery. 2007;94:683–688. doi: 10.1002/bjs.5837.
    1. Imamura H., Kurokawa Y., Tsujinaka T., et al. Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial. The Lancet Infectious Diseases. 2012;12:381–387. doi: 10.1016/S1473-3099(11)70370-X.
    1. Zhou H., Zhang J., Wang Q., Hu Z. Meta-analysis: antibiotic prophylaxis in elective laparoscopic cholecystectomy. Alimentary Pharmacology & Therapeutics. 2009;29:1086–1095. doi: 10.1111/j.1365-2036.2009.03977.x.
    1. Horan T. C., Gaynes R. P., Martone W. J., Jarvis W. R., Emori T. G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology. 1992;13:606–608. doi: 10.1017/S0195941700015241.
    1. Weinstein R. A., Sessler D. I., Akça O. Nonpharmacological prevention of surgical wound infections. Clinical Infectious Diseases. 2002;35:1397–1404.
    1. Sumiyama Y., Takesue Y. Current status of prophylactic antibiotic therapy for prevention of postoperative infections after gastrointestinal surgery: a questionnaire covering 3,823 surgeons. Japanese Journal Chemotherapy. 2004;52:474–485.
    1. Ahn H. S., Yook J. H., Park C. H., et al. General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer. 2011;14:178–182. doi: 10.1007/s10120-011-0012-x.
    1. Carlet J., Collignon P., Goldmann D., et al. Society’s failure to protect a precious resource: antibiotics. The Lancet. 2011;378:369–371. doi: 10.1016/S0140-6736(11)60401-7.
    1. Rossolini G. M., Arena F., Pecile P., Pollini S. Update on the antibiotic resistance crisis. Current Opinion in Pharmacology. 2014;15:56–60.
    1. Allegranzi B., Bischoff P., de Jonge S., et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. The Lancet Infectious Diseases. 2016;16:e276–ee87. doi: 10.1016/S1473-3099(16)30398-X.
    1. Wenisch C., Narzt E., Sessler D. I., et al. Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes. Anesthesia and Analgesia. 1996;82:810–816.
    1. Kurz A., Sessler D. I., Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. The New England Journal of Medicine. 1996;334:1209–1216. doi: 10.1056/NEJM199605093341901.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться